- $9.6 million net revenue with an improved sales mix focused on the high-growth adult-use and recurring medical cannabis sales channels
- 2,044% y/y increase in adult-use cannabis net revenue
- 31% y/y increase in medical cannabis net revenue
- Top 10 in national market share in pre-rolls achieved subsequent to the reporting period 1
- Top 10 in national adult-use market share in edibles and oils categories 1
- Outdoor harvest produced average yield on THC-dominant dried flower of 22%
- SG&A expenses declined 24% over the previous quarter
- Strengthened product portfolio with a total of 35 and 46 SKUs listed in Ontario and Alberta respectively by January 2022
TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE)